<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">This study was performed at two regional reference laboratories, with the following aims: I) to assess the analytical performances of the newly designed Simplexaâ„¢ COVID-19 Direct assay; II) to evaluate its clinical performance as compared to WHO protocols [
 <xref rid="bib0035" ref-type="bibr">7</xref>,
 <xref rid="bib0040" ref-type="bibr">8</xref>] using different types of clinical specimens from patients with laboratory-confirmed COVID-19.
</p>
